PT-141
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist investigated for melanocortin-mediated CNS signaling and sexual function pathways.
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from the metabolite of Melanotan II. In preclinical laboratory research, PT-141 is investigated for its selective activity at melanocortin receptors MC3R and MC4R, distinguishing it from broader melanocortin agonists. The peptide’s cyclic lactam structure and C-terminal free acid (rather than amide) differentiate it structurally from its parent compound Melanotan II. PT-141 serves as a key pharmacological tool for studying melanocortin receptor-mediated central nervous system pathways, particularly those involved in sexual function, arousal signaling, and hypothalamic neuroendocrine regulation.
- Peptide
- PT-141 (Bremelanotide)
- Strength
- 10 mg
- Package
- 10 mg
- Purity
- 99.33%
- Form
- vial
